Potential Role of Ginseng in the Treatment of Colorectal Cancer

American Journal of Chinese Medicine - Tập 36 Số 06 - Trang 1019-1028 - 2008
Chong‐Zhi Wang1, Chun‐Su Yuan1
1Tang Center for Herbal Medicine Research and Department of Anesthesia and Critical Care, The University of Chicago, Chicago, Illinois 60637, USA

Tóm tắt

Colorectal cancer remains one of the most prevalent cancer and a leading cause of cancer related death in the US. Many currently used chemotherapeutic agents are derived from botanicals. Identifying herbal sources, including those from ginseng family, to develop better anti-cancer therapies remains an essential step in advancing the treatment of the cancer. In this article, potential roles of ginseng herbs, especially American ginseng and notoginseng, in colorectal cancer therapeutics are presented. The major pharmacologically active constituents of ginsengs are ginsenosides, which can be mainly classified as protopanaxadiol and protopanaxatriol groups. Structure-activity relationship between their chemical structures and pharmacological activities are discussed. In addition, various steaming temperature and time treatment of the ginseng herbs can change ginsenoside profiles, and enhance their anti-cancer activities. This heat treatment process may increase the role of ginseng in treating colorectal cancer.

Từ khóa


Tài liệu tham khảo

Akerele O., World Health Forum, 14, 390

10.1021/jf030042h

10.1016/S0006-2952(99)00212-9

10.1007/s00280-006-0278-6

Barnes P. M., Adv. Data, 343, 1

10.1111/j.1469-7580.2008.00864.x

10.1142/S0192415X06004533

10.1142/S0192415X0100054X

Chen Y., Zhong Yao Cai, 25, 176

10.1016/j.lfs.2005.07.010

10.1016/S1570-0232(04)00645-2

10.1200/JCO.2004.09.046

Helms S., Altern. Med. Rev., 9, 259

10.1056/NEJMoa032691

10.1023/A:1018491314066

10.3322/CA.2007.0010

10.1139/y04-049

10.1016/S1043-6618(03)00189-0

10.1007/BF02980085

10.1142/S0192415X07004850

10.1023/A:1007078414639

10.1142/S0192415X07004710

10.1016/j.chroma.2004.09.069

10.1254/jjp.21.299

10.1142/S0192415X06003618

10.1142/S0192415X07005077

10.1016/j.molmed.2007.11.002

10.1142/S0192415X06004508

10.1142/S0192415X06004557

10.1007/s11655-007-9002-6

10.1001/archinte.158.20.2225

10.1007/s00280-004-0956-1

10.1248/bpb.18.1197

10.1142/S0192415X06003692

10.1211/jpp.58.8.0001

10.1142/S0192415X06004041

10.1046/j.1523-5394.2002.103004.x

10.1142/S0192415X07005314

10.1016/S0003-9861(02)00398-3

10.1142/S0192415X06003801

10.1002/cbdv.200590032

10.1007/s11418-005-0027-x

10.1021/jf052993w

10.1021/jf062467k

10.1055/s-2007-981524

10.1007/s00280-006-0350-2

10.1142/S0192415X07005053

10.1007/s00280-006-0300-z

10.1021/ac980890p

10.1592/phco.21.9.773.34561

10.1142/S0192415X07004928

10.1142/S0192415X07005326

10.1142/S0192415X06003825

Xu S. X., Yao Xue Xue Bao, 22, 750

10.1142/S0192415X06004521

10.1142/S0192415X06003709

Yun T. K., Mutat. Res., 523

Yun T. K., Cancer Epidemiol. Biomarkers Prev., 4, 401

10.1093/ije/27.3.359

10.3346/jkms.2001.16.S.S6

10.1142/S0192415X07005065